Completed PHASE3 INTERVENTIONAL 1-arm NCT02025491

Liposomal Amphotericin in Disseminated Leishmaniasis

Efficacy Study of Liposomal Amphotericin in Disseminated Leishmaniasis

Sponsor: Hospital Universitário Professor Edgard Santos

Updated 5 times since 2017 Last updated: Dec 30, 2013 Started: Apr 30, 2011 Primary completion: Feb 28, 2013 Completion: Aug 31, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02025491, this PHASE3 trial focuses on Disseminated Leishmaniasis and remains completed. Sponsored by Hospital Universitário Professor Edgard Santos, it has been updated 5 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Universitário Professor Edgard Santos

Data source: Hospital Universitário Professor Edgard Santos

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Salvador, Brazil